{"success":true,"data":{"pressRelease":{"id":"153871","rtpr_id":"nBw1CVlbXa-20260928","ticker":"CTEC","exchange":"LSE","all_tickers":["CTEC"],"title":"Convatec Expands Cure™ Portfolio With Launch of Cure Aqua™, Bringing Greater Choice to People Who Catheterize","author":"Business Wire","published_at":"2026-09-28T11:00:00.327Z","article_body":"Convatec Expands Cure(™) Portfolio With Launch of Cure Aqua(™), Bringing\nGreater Choice to People Who Catheterize\n\n * New ready-to-use hydrophilic catheter designed to make self-catheterization a\nsmaller part of everyday life, launching initially across the US and Canada in\nSeptember, with other markets to follow.\nConvatec, a leading medical products and technologies company focused on\nsolutions for the management of chronic conditions, announces the launch of\nCure Aqua™ in the United States and Canada.\n\nThe latest addition to Convatec’s Cure™ catheter portfolio, Cure Aqua™\nis a ready-to-use hydrophilic intermittent catheter designed to support a\ncomfortable catheterization experience while helping simplify daily routines.\nDeveloped with direct input from people who catheterize, Cure Aqua™ combines\nuser-centered design with practical, comfort-focused features to help make\nself-catheterization a smaller part of everyday life.\n\nCure Aqua™ is ready to use with no activation step required(1). Key\nfeatures(1) include:\n\n * A hydrophilic coating designed for a comfortable, low-friction catheterization\nexperience\n * A no-touch handling sleeve to help reduce contamination risk\n * Unique fire-polished eyelets designed for comfortable insertion\n * Easy-open packaging and an opaque design for greater privacy\n * Materials free from DEHP/DINP, BPA and natural rubber latex\n * Distinctive blue control stripe, a well-recognized feature across the Cure\nportfolio that supports proper Coudé-tip orientation during use\nCure Aqua(™) is available in female, male and pediatric options, providing\nchoice across a range of patient needs, lifestyles and preferences.\n\nMark Jassey, President, Continence Care & Home Services Group, said: “At\nConvatec, we believe the most impactful innovation starts with understanding\nthe experiences of the people we serve and ensuring we provide meaningful\nchoice to reflect individual needs and lifestyles. The launch of Cure\nAqua(™) is another step in expanding access to solutions that help people\nself-catheterize with greater confidence and independence, while advancing our\nvision: Pioneering trusted medical solutions to improve the lives we touch.”\n\nThe launch of Cure Aqua(™) further strengthens Convatec's Cure(™) catheter\nportfolio of innovative, user-centered continence care solutions. Founded by a\ncatheter user, the Cure(™) brand has long focused on delivering solutions\ndesigned around the people who use them. The addition of Cure Aqua(™)\nexpands choice for healthcare professionals and users, helping ensure more\npeople across North America find a solution that fits their individual needs,\npreferences and lifestyles.\n\nAs Convatec continues to advance its strongest innovation pipeline in its\nhistory, the company remains focused on delivering trusted medical solutions\nto more people, including the planned launch of GentleCath Air Pocket(™)\n& GentleCath Air Set(™) in Europe expected later this year.\n\nBeyond innovative products, Convatec supports people through me+, its\npersonalized support program designed to help people living with chronic\nhealth conditions with practical, social and emotional guidance, compassionate\ncare, and meaningful connection to help individuals navigate every stage of\ntheir journey. Together, products and services like me+ reflect Convatec's\nforever caring promise, helping people live with greater confidence while\nimproving experiences and outcomes.\n\nReferences\n\n1. Data on file\n\nAbout Convatec\n\nPioneering trusted medical solutions to improve the lives we touch: Convatec\nis a global medical products and technologies company focused on solutions for\nthe management of chronic conditions, with leading positions in Advanced Wound\nCare, Ostomy Care, Continence Care and Infusion Care. With over 10,000\ncolleagues, we provide products and services in around 90 countries, united by\na promise to be forever caring. Our solutions provide a range of benefits,\nfrom infection prevention and treatment for hard-to-heal wounds, at-risk skin\nand ulcerated tissue to support for debilitating conditions, improved patient\noutcomes and reduced care costs. Convatec’s revenues in 2025 were over $2\nbillion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To\nlearn more, please visit http://www.convatecgroup.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.convatecgroup.com%2F&esheet=54611774&newsitemid=20260928053012&lan=en-US&anchor=http%3A%2F%2Fwww.convatecgroup.com&index=1&md5=3145dc52e77dead888a5b4e7d9cba1d5)\n.\n\nAP-82066-GBL-ENG-v2\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260928053012/en/\n(https://www.businesswire.com/news/home/20260928053012/en/)\n\nMedia: mediarelations@convatec.com (mailto:mediarelations@convatec.com) \nInvestor Relations: IR@convatec.com (mailto:IR@convatec.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw1CVlbXa-20260928","title":"Convatec Expands Cure™ Portfolio With Launch of Cure Aqua™, Bringing Greater Choice to People Who Catheterize","author":"Business Wire","ticker":"CTEC","created":"2026-09-28T11:00:00.327Z","tickers":["CTEC"],"exchange":"LSE","article_body":"Convatec Expands Cure(™) Portfolio With Launch of Cure Aqua(™), Bringing\nGreater Choice to People Who Catheterize\n\n * New ready-to-use hydrophilic catheter designed to make self-catheterization a\nsmaller part of everyday life, launching initially across the US and Canada in\nSeptember, with other markets to follow.\nConvatec, a leading medical products and technologies company focused on\nsolutions for the management of chronic conditions, announces the launch of\nCure Aqua™ in the United States and Canada.\n\nThe latest addition to Convatec’s Cure™ catheter portfolio, Cure Aqua™\nis a ready-to-use hydrophilic intermittent catheter designed to support a\ncomfortable catheterization experience while helping simplify daily routines.\nDeveloped with direct input from people who catheterize, Cure Aqua™ combines\nuser-centered design with practical, comfort-focused features to help make\nself-catheterization a smaller part of everyday life.\n\nCure Aqua™ is ready to use with no activation step required(1). Key\nfeatures(1) include:\n\n * A hydrophilic coating designed for a comfortable, low-friction catheterization\nexperience\n * A no-touch handling sleeve to help reduce contamination risk\n * Unique fire-polished eyelets designed for comfortable insertion\n * Easy-open packaging and an opaque design for greater privacy\n * Materials free from DEHP/DINP, BPA and natural rubber latex\n * Distinctive blue control stripe, a well-recognized feature across the Cure\nportfolio that supports proper Coudé-tip orientation during use\nCure Aqua(™) is available in female, male and pediatric options, providing\nchoice across a range of patient needs, lifestyles and preferences.\n\nMark Jassey, President, Continence Care & Home Services Group, said: “At\nConvatec, we believe the most impactful innovation starts with understanding\nthe experiences of the people we serve and ensuring we provide meaningful\nchoice to reflect individual needs and lifestyles. The launch of Cure\nAqua(™) is another step in expanding access to solutions that help people\nself-catheterize with greater confidence and independence, while advancing our\nvision: Pioneering trusted medical solutions to improve the lives we touch.”\n\nThe launch of Cure Aqua(™) further strengthens Convatec's Cure(™) catheter\nportfolio of innovative, user-centered continence care solutions. Founded by a\ncatheter user, the Cure(™) brand has long focused on delivering solutions\ndesigned around the people who use them. The addition of Cure Aqua(™)\nexpands choice for healthcare professionals and users, helping ensure more\npeople across North America find a solution that fits their individual needs,\npreferences and lifestyles.\n\nAs Convatec continues to advance its strongest innovation pipeline in its\nhistory, the company remains focused on delivering trusted medical solutions\nto more people, including the planned launch of GentleCath Air Pocket(™)\n& GentleCath Air Set(™) in Europe expected later this year.\n\nBeyond innovative products, Convatec supports people through me+, its\npersonalized support program designed to help people living with chronic\nhealth conditions with practical, social and emotional guidance, compassionate\ncare, and meaningful connection to help individuals navigate every stage of\ntheir journey. Together, products and services like me+ reflect Convatec's\nforever caring promise, helping people live with greater confidence while\nimproving experiences and outcomes.\n\nReferences\n\n1. Data on file\n\nAbout Convatec\n\nPioneering trusted medical solutions to improve the lives we touch: Convatec\nis a global medical products and technologies company focused on solutions for\nthe management of chronic conditions, with leading positions in Advanced Wound\nCare, Ostomy Care, Continence Care and Infusion Care. With over 10,000\ncolleagues, we provide products and services in around 90 countries, united by\na promise to be forever caring. Our solutions provide a range of benefits,\nfrom infection prevention and treatment for hard-to-heal wounds, at-risk skin\nand ulcerated tissue to support for debilitating conditions, improved patient\noutcomes and reduced care costs. Convatec’s revenues in 2025 were over $2\nbillion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To\nlearn more, please visit http://www.convatecgroup.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.convatecgroup.com%2F&esheet=54611774&newsitemid=20260928053012&lan=en-US&anchor=http%3A%2F%2Fwww.convatecgroup.com&index=1&md5=3145dc52e77dead888a5b4e7d9cba1d5)\n.\n\nAP-82066-GBL-ENG-v2\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260928053012/en/\n(https://www.businesswire.com/news/home/20260928053012/en/)\n\nMedia: mediarelations@convatec.com (mailto:mediarelations@convatec.com) \nInvestor Relations: IR@convatec.com (mailto:IR@convatec.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-09-28T11:00:00.557795293Z","server_sent_at_ms":1790593200557},"received_at":"2026-09-28T11:00:00.608Z","source_url":"https://www.businesswire.com/news/home/20260928053012/en/"},"analysis":{"id":"142659","press_release_id":"153871","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":[],"eventType":"product_launch","narrative":"Convatec launched Cure Aqua™, a ready-to-use hydrophilic intermittent catheter, in the US and Canada in September, with other markets to follow.\n\nThe launch expands the company's Cure™ catheter portfolio with female, male and pediatric options designed for comfort and ease of use.\n\nConvatec, a FTSE 100 medical products company with 2025 revenues over $2 billion, also flagged a planned European launch of GentleCath Air Pocket™ & GentleCath Air Set™ later this year.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Portfolio expansion in continence care -- incremental, not a needle-mover for CTEC near-term."},"keyFigures":{"customDimensions":{"revenue_2025":"$2 billion"}},"quotedText":"At Convatec, we believe the most impactful innovation starts with understanding the experiences of the people we serve","namedEntities":{"people":[{"name":"Mark Jassey","role":"President, Continence Care & Home Services Group"}],"products":["Cure Aqua™","GentleCath Air Pocket™","GentleCath Air Set™","me+"],"companies":[{"name":"Convatec","ticker":"CTEC","relationship":"filer/issuer"}],"dollarAmounts":[{"amount":"over $2 billion","context":"Convatec revenues in 2025"}]},"materialImpact":{"score":2,"reasoning":"Routine but positive product launch expanding the Cure catheter portfolio in the US and Canada. No financial figures specific to the launch; incremental revenue impact unclear in the near term."},"tickerRelevance":{"others":[],"primary":"CTEC"},"globalImportance":22,"audienceRelevance":18,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"large-cap-european","eventGravity":"routine-product-launch","sectorWeight":"medtech","householdBrandBoost":0}},"event_type":"product_launch","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Convatec launched Cure Aqua™, a ready-to-use hydrophilic intermittent catheter, in the US and Canada in September, with other markets to follow.\n\nThe launch expands the company's Cure™ catheter portfolio with female, male and pediatric options designed for comfort and ease of use.\n\nConvatec, a FTSE 100 medical products company with 2025 revenues over $2 billion, also flagged a planned European launch of GentleCath Air Pocket™ & GentleCath Air Set™ later this year.","key_figures":{"customDimensions":{"revenue_2025":"$2 billion"}},"named_entities":{"people":[{"name":"Mark Jassey","role":"President, Continence Care & Home Services Group"}],"products":["Cure Aqua™","GentleCath Air Pocket™","GentleCath Air Set™","me+"],"companies":[{"name":"Convatec","ticker":"CTEC","relationship":"filer/issuer"}],"dollarAmounts":[{"amount":"over $2 billion","context":"Convatec revenues in 2025"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-28T11:00:07.177Z","global_importance":22,"audience_relevance":18,"importance_components":{"tickerTier":"large-cap-european","eventGravity":"routine-product-launch","sectorWeight":"medtech","householdBrandBoost":0}},"durationMs":6551,"modelName":"glm-5.3-flashx"}}